or Try an Advanced Search...

    Technical Analysis for ALLO - Allogene Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 2.76 -5.15% -0.15
    ALLO closed down 5.15 percent on Wednesday, May 8, 2024, on 53 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ALLO trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Wide Bands Range Expansion -5.15%
    MACD Bullish Signal Line Cross Bullish -8.31%
    NR7 Range Contraction -8.31%
    Wide Bands Range Expansion -8.31%
    Shooting Star Candlestick Bearish -10.10%
    Doji - Bearish? Reversal -10.10%
    Wide Bands Range Expansion -10.10%
    Older End-of-Day Signals for ALLO ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 11 hours ago
    Down 5% about 12 hours ago
    60 Minute Opening Range Breakdown about 13 hours ago
    Down 3% about 15 hours ago
    Fell Below Previous Day's Low about 15 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ALLO Chart by TradingView
    Basic chart:

    Profile

    Allogene Therapeutics is a clinical stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer. Led by a world-class management team with significant experience in cell therapy, we are developing a pipeline of “off-the-shelf” CAR T cell therapy candidates with the goal of delivering readily available cell therapy faster, more reliably and at greater scale to more patients.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Stem Cell Cell Therapy Cell Biology Therapies For Cancer Adoptive Cell Transfer

    Is ALLO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 6 Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
    Apr 26 Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
    Apr 25 Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
    Apr 24 Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?
    Apr 18 To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
    Apr 11 3 Meme Stocks to Sell and Replace With Meme Coins
    Apr 9 Allogene Therapeutics Announces Q2 Investor Conference Participation
    Apr 7 We Think Allogene Therapeutics (NASDAQ:ALLO) Needs To Drive Business Growth Carefully
    Apr 1 Allogene Therapeutics: 2024 Platform Vision Sings Mid-Term Upside
    Mar 16 Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript
    See more ALLO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.89
    52 Week Low 2.23
    Average Volume 2,149,135
    200-Day Moving Average 3.63
    50-Day Moving Average 4.04
    20-Day Moving Average 3.20
    10-Day Moving Average 2.90
    Average True Range 0.23
    RSI (14) 28.06
    ADX 27.74
    +DI 17.46
    -DI 31.66
    Chandelier Exit (Long, 3 ATRs) 3.55
    Chandelier Exit (Short, 3 ATRs) 3.40
    Upper Bollinger Bands 3.91
    Lower Bollinger Band 2.49
    Percent B (%b) 0.19
    BandWidth 44.38
    MACD Line -0.32
    MACD Signal Line -0.33
    MACD Histogram 0.0112
    Fundamentals Value
    Market Cap 464.44 Million
    Num Shares 168 Million
    EPS -2.20
    Price-to-Earnings (P/E) Ratio -1.25
    Price-to-Sales 3962.65
    Price-to-Book 1.26
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.94
    Resistance 3 (R3) 2.95 2.91 2.91
    Resistance 2 (R2) 2.91 2.86 2.90 2.90
    Resistance 1 (R1) 2.83 2.83 2.81 2.82 2.89
    Pivot Point 2.79 2.79 2.78 2.78 2.79
    Support 1 (S1) 2.71 2.74 2.69 2.70 2.63
    Support 2 (S2) 2.67 2.71 2.66 2.62
    Support 3 (S3) 2.59 2.67 2.61
    Support 4 (S4) 2.58